• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠肿瘤中 Dclk1 细胞的基因表达谱。

Gene expression profile of Dclk1 cells in intestinal tumors.

机构信息

Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

出版信息

Dig Liver Dis. 2018 Dec;50(12):1353-1361. doi: 10.1016/j.dld.2018.06.011. Epub 2018 Jun 22.

DOI:10.1016/j.dld.2018.06.011
PMID:30001952
Abstract

BACKGROUND

Accumulating evidence has shown the existence of tumor stem cells with therapeutic potential. Previously, we reported that doublecortin like kinase 1 (Dclk1) marks tumor stem cells but not normal stem cells in the intestine of Apc mice, and that Dclk1- and Lgr5-double positive tumor cells are the tumor stem cells of intestinal tumors.

AIM

To investigate molecules highly expressed in the Dclk1 normal intestinal and Dclk1 tumor cells in Apc mice.

METHODS

We used microarray analyses to examine the gene expression profile of Dclk1 cells in both mouse normal intestinal epithelium and Apc mouse intestinal tumors. We also performed immunofluorescence analyses.

RESULTS

Genes related to microtubules and the actin cytoskeleton (e.g., Rac2), and members of the Src family kinases (i.e., Hck, Lyn, Csk, and Ptpn6) were highly expressed in both Dclk1 normal intestinal and Dclk1 tumor cells. Phosphorylated Hck and phosphorylated Lyn were expressed in Lgr5 cells in the intestinal tumors of Lgr5; Apc mice.

CONCLUSION

We revealed factors that are highly expressed in Dclk1 intestinal tumor cells, which may help to develop cancer stem cell-targeted therapy in future.

摘要

背景

越来越多的证据表明存在具有治疗潜力的肿瘤干细胞。此前,我们报道了双皮质激酶 1(Dclk1)标记了 Apc 小鼠肠道中的肿瘤干细胞而非正常干细胞,并且 Dclk1 和 Lgr5 双阳性肿瘤细胞是肠道肿瘤的肿瘤干细胞。

目的

研究 Apc 小鼠中 Dclk1 正常肠细胞和 Dclk1 肿瘤细胞中高度表达的分子。

方法

我们使用微阵列分析来检测 Dclk1 细胞在正常小鼠肠道上皮和 Apc 小鼠肠道肿瘤中的基因表达谱。我们还进行了免疫荧光分析。

结果

与微管和肌动蛋白细胞骨架相关的基因(例如 Rac2)以及Src 家族激酶的成员(即 Hck、Lyn、Csk 和 Ptpn6)在 Dclk1 正常肠细胞和 Dclk1 肿瘤细胞中均高度表达。在 Lgr5;Apc 小鼠的肠道肿瘤中,磷酸化 Hck 和磷酸化 Lyn 表达于 Lgr5 细胞中。

结论

我们揭示了在 Dclk1 肠道肿瘤细胞中高度表达的因子,这可能有助于未来开发针对癌症干细胞的治疗方法。

相似文献

1
Gene expression profile of Dclk1 cells in intestinal tumors.肠肿瘤中 Dclk1 细胞的基因表达谱。
Dig Liver Dis. 2018 Dec;50(12):1353-1361. doi: 10.1016/j.dld.2018.06.011. Epub 2018 Jun 22.
2
Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.双皮质素样激酶1(Dclk1)是一种肿瘤干细胞标志物,可调节肠道肿瘤细胞的促生存信号传导和自我更新。
Mol Cancer. 2017 Feb 1;16(1):30. doi: 10.1186/s12943-017-0594-y.
3
Dclk1 distinguishes between tumor and normal stem cells in the intestine.Dclk1 区分肠道中的肿瘤和正常干细胞。
Nat Genet. 2013 Jan;45(1):98-103. doi: 10.1038/ng.2481. Epub 2012 Dec 2.
4
DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition.双皮质素样激酶1(DCLK1)通过增强多能性和上皮间质转化促进肠道肿瘤生长。
Oncotarget. 2014 Oct 15;5(19):9269-80. doi: 10.18632/oncotarget.2393.
5
Elp3 drives Wnt-dependent tumor initiation and regeneration in the intestine.Elp3驱动肠道中Wnt依赖的肿瘤起始和再生。
J Exp Med. 2015 Nov 16;212(12):2057-75. doi: 10.1084/jem.20142288. Epub 2015 Nov 2.
6
A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?对癌症干细胞标志物的新见解:结直肠癌中局部和循环癌症干细胞标志物是否相关?
Tumour Biol. 2016 Feb;37(2):2405-14. doi: 10.1007/s13277-015-3989-7. Epub 2015 Sep 17.
7
Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.在接受放化疗的结直肠癌患者中,循环癌干细胞标志物DCLK1而非Lgr5上调。
Tumour Biol. 2015 Jun;36(6):4801-10. doi: 10.1007/s13277-015-3132-9. Epub 2015 Jan 29.
8
Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis.双皮质素样激酶 1 和富含亮氨酸重复序列的 G 蛋白偶联受体 5 在 II/III 期结直肠癌患者中的作用:癌症进展和预后。
World J Gastroenterol. 2020 Nov 21;26(43):6853-6866. doi: 10.3748/wjg.v26.i43.6853.
9
The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer.最近提出的肠癌细胞标志物 DCLK1 是结直肠癌的一种表观遗传生物标志物。
Epigenetics. 2014 Mar;9(3):346-50. doi: 10.4161/epi.27582. Epub 2014 Jan 2.
10
[A tumor stem cell-specific marker identified by lineage tracing in the intestine].[通过肠道谱系追踪鉴定的肿瘤干细胞特异性标志物]
Nihon Rinsho. 2015 May;73(5):850-4.

引用本文的文献

1
Appearance of tuft cells during prostate cancer progression.前列腺癌进展过程中簇状细胞的出现。
Oncogene. 2023 Jul;42(31):2374-2385. doi: 10.1038/s41388-023-02743-1. Epub 2023 Jun 29.
2
Pleiotropic effects of DCLK1 in cancer and cancer stem cells.DCLK1在癌症和癌症干细胞中的多效性作用。
Front Mol Biosci. 2022 Sep 26;9:965730. doi: 10.3389/fmolb.2022.965730. eCollection 2022.
3
Transcriptional dynamics of colorectal cancer risk associated variation at 11q23.1 correlate with tuft cell abundance and marker expression in silico.
11q23.1 上与结直肠癌风险相关变异的转录动力学与网上类肠嗜铬细胞丰度和标志物表达相关。
Sci Rep. 2022 Aug 10;12(1):13609. doi: 10.1038/s41598-022-17887-5.
4
Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis.双皮质素样激酶 1 和富含亮氨酸重复序列的 G 蛋白偶联受体 5 在 II/III 期结直肠癌患者中的作用:癌症进展和预后。
World J Gastroenterol. 2020 Nov 21;26(43):6853-6866. doi: 10.3748/wjg.v26.i43.6853.
5
Lineage tracing and targeting of IL17RB tuft cell-like human colorectal cancer stem cells.IL17RB 微绒毛发细胞样人结直肠癌干细胞的谱系追踪和靶向。
Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):12996-13005. doi: 10.1073/pnas.1900251116. Epub 2019 Jun 10.